The results of our study, presenting new significant associations with the IBD locus in the CXCL8 gene and defining for the first time IL-8 concentration in IBD p.Glu31Ter carriers, need further confirmation from other populations and functional studies before it may constitute a promising therapeutic value for IBD in the future. The gene discussed is CXCL8; the disease is inflammatory bowel disease.